Jci_page_head_homepage_01 Jci_page_head_homepage_02
Polly A. Quiram, Kinji Ohno, Margherita Milone, Marc C. Patterson, Ned J. Pruitt, Joan M. Brengman, Steven M. Sine, Andrew G. Engel
Published in Volume 104, Issue 10
J Clin Invest. 1999; 104(10):1403–1410 doi:10.1172/JCI8179
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 2

(a) Schematic presentation of the positions of the identified mutations in the AChR β subunit gene. (b) Multiple alignment of the long cytoplasmic loop of AChR subunits around the β1276del9 mutation. β1276del9 predicts an in-frame deletion of EQE codons at 426–428 (underlined). (c) Size fractionation of PstI-digested PCR products amplified from genomic DNA from blood of family members. The β1276del9 mutation results in a 61-bp fragment, whereas the wild-type allele gives rise to a 70-bp fragment. The father and 3 affected siblings are heterozygous for β1276del9. Arrow indicates patient; filled symbols indicate affected individuals. (d) Size fractionation of RT-PCR products of the AChR β subunit gene amplified with primers in exon 7 and 9. The normal transcript yields a 350-bp fragment; skipping of exon 8 results in a 126-bp fragment. Mother and patient carry both transcripts. Skipping of exon 8 was confirmed by direct sequencing.